Who we are.

Paul was appointed as CEO of Inizio in November 2021. Before then, he served as CEO of Huntsworth for nearly six years. Paul has wide experience in communications and marketing from roles such as the Director of Communications at Groupon, the international e-commerce company. Prior to that, he enjoyed a 20 year career with Hill & Knowlton Inc, the global communications consultancy and subsidiary of WPP plc, including nine years as its Chairman and CEO. Throughout this time he advised many Blue Chip and international clients across all geographies, sectors and services.

Previously COO at UDG Healthcare, before being appointed to Inizio in November 2021, Ryan provides strategic leadership across our global divisions by working with the executive management teams to establish and deliver long-term strategic growth plans. He has over 25 years’ experience in the pharmaceutical industry in commercial leadership roles. Prior to joining UDG, Ryan was Regional Vice President Region South, Immunology and HCV lead for AbbVie Western Europe and Canada.

Ben was appointed Chief Financial Officer of Inizio following the acquisition of UDG Healthcare, having previously been CFO of Huntsworth Plc. Ben joined Huntsworth Plc in September 2016, stepping up to the Board in 2019. Before joining the team, he worked at ITE Plc, and International Exhibitions Organizer, as Group Financial Controller. Prior to that Ben worked at Royal Bank of Scotland in banking roles, after training and qualifying with Deloitte in London.

Grainne became part of the Inizio team after joining UDG Healthcare in June 2018 as the UDG Head of Finance, with responsibility for Group Finance, Ashfield Finance Functions, Global Procurement & Real Estate, and Finance Transformation. Prior to UDG, she worked as General Manager, Ireland and Vice President, Finance with Alexion, a rare disease US biotech company, leading their expansion in Ireland and a €500 million investment in biologics and packaging facilities in Ireland. Grainne previously spent ten years working with Elan Pharmaceuticals in the United States and Ireland in various corporate, strategic and group finance roles. Externally, Grainne is a Board Director for Science Foundation Ireland, the national funding body for STEM research in Ireland.

Stephanie joined Inizio as the Global Chief Human Resources Officer (CHRO) in September 2022. She leads Inizio's global talent strategy and HR team, focusing on transforming the HR organization to deliver a best-in-class experience for our people and differentiating Inizio in the market as a global employer of choice. With over 25 years of international experience as a strategy and management consultant, corporate leader, Chief Human Resources Officer and Board member, Stephanie brings a wealth of global knowledge and expertise from across various industries including professional services, financial services, and engineering/construction.

Neil is an experienced Executive Director. He was the former CFO & COO of Huntsworth, having joined the Group in early 2016. Before joining Huntsworth, Neil was CFO for a number of UK-listed public companies in the B2B international exhibition sector, having originally qualified as an accountant with PWC in the early 90’s. Neil now leads M&A activities and the support functions for Inizio. He also acts as CEO for the wider Group’s Communications Division, Accordience which houses predominantly non-healthcare PR agencies, and acts as a Non-Executive Director on two public companies listed in New York and London.

Previously, Inizio Advisory's Global President since September 2019, Colin Stanley has extensive experience in Senior Executive roles. He has been responsible for a business unit of 3,000 employees globally, providing strategic resourcing and functional services. He also held a number of roles during his 20-year career at ICON, including Chief Operating Officer of DOCS and Vice President of Clinical Operations in Asia.

Joining Medistrava in 2015, Elaine helped double the size of the organization through organic growth and acquisition to create a fully integrated medical, health economics and market access platform. Now, she joins us as President of Inizio Medical. As a trained neuropsychologist, Elaine has enjoyed a career in research and clinical practice before joining the industry, combining her background in science and behavior to drive evidence-based strategies that apply to real-world healthcare challenges.

As CEO & Founder of Evoke, Reid leads the organization globally. Reid founded Evoke in 2006 in pursuit of a simple yet powerful idea—to make health more human™. This idea caught fire with like-minded clients who were hungry for rich, insight-driven strategies that drive real change for brands and people.

Joining Ashfield in 2005 as a Regional Account Director in the UK, Greg Flynn has since worked with our teams across the UK, Japan and the US. He established and ran our joint venture in Japan before moving to the US in 2017 to lead Engage. Greg was previously the President of Engage from 2019 - 2025.